Chemicalinfo & Chemlink & Pharm-Chem Nethttp://www.chemlink.org/blog/Pharmaceutical Chemical Online BlogRainbowSoft Studio Z-Blog 1.7 Laputa Build 70216zh-CNCopyright 2005-2009 Your WebSite. Some Rights Reserved.Sun, 24 Oct 2010 23:12:03 +0800IMS心脑血管类药物2009-2018年预测报告（一）sales@chemlink.org (admin)http://www.chemlink.org/blog/post/102.htmlSun, 24 Oct 2010 23:09:39 +0800http://www.chemlink.org/blog/post/102.htmlSourcehttp://www.chemlink.org/blog/post/102.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=102http://www.chemlink.org/blog/cmd.asp?act=tb&id=102&key=dc155f14FDA approves Pradaxa(dabigatran etexilate) to prevent stroke in people with atrial fibrillationsales@chemlink.org (admin)http://www.chemlink.org/blog/post/101.htmlSun, 24 Oct 2010 21:02:33 +0800http://www.chemlink.org/blog/post/101.htmlNewshttp://www.chemlink.org/blog/post/101.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=101http://www.chemlink.org/blog/cmd.asp?act=tb&id=101&key=09b16c3eA Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer Lapatinibsales@chemlink.org (admin)http://www.chemlink.org/blog/post/100.htmlSun, 24 Oct 2010 20:57:31 +0800http://www.chemlink.org/blog/post/100.htmlNewshttp://www.chemlink.org/blog/post/100.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=100http://www.chemlink.org/blog/cmd.asp?act=tb&id=100&key=11ed7ee0GTx Announces Ostarine Increased Lean Body Mass and Leg Press Strength in Head to Head Clinical Studysales@chemlink.org (admin)http://www.chemlink.org/blog/post/99.htmlFri, 15 Oct 2010 09:07:43 +0800http://www.chemlink.org/blog/post/99.htmlNewshttp://www.chemlink.org/blog/post/99.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=99http://www.chemlink.org/blog/cmd.asp?act=tb&id=99&key=260213ceGilenya (Fingolimod HCl) First Oral MS Drug, Gets FDA Nodsales@chemlink.org (admin)http://www.chemlink.org/blog/post/96.htmlTue, 12 Oct 2010 11:26:04 +0800http://www.chemlink.org/blog/post/96.htmlNewshttp://www.chemlink.org/blog/post/96.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=96http://www.chemlink.org/blog/cmd.asp?act=tb&id=96&key=6fa2b9832009年国际一线药企重点研发产品时间表sales@chemlink.org (admin)http://www.chemlink.org/blog/post/93.htmlWed, 27 Jan 2010 22:02:37 +0800http://www.chemlink.org/blog/post/93.htmlNewshttp://www.chemlink.org/blog/post/93.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=93http://www.chemlink.org/blog/cmd.asp?act=tb&id=93&key=c59a3a9b治疗白血病的蛋白激酶抑制剂 Bosutinibsales@chemlink.org (admin)http://www.chemlink.org/blog/post/92.htmlTue, 26 Jan 2010 10:05:51 +0800http://www.chemlink.org/blog/post/92.htmlNewshttp://www.chemlink.org/blog/post/92.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=92http://www.chemlink.org/blog/cmd.asp?act=tb&id=92&key=97139aaf新型糖尿病药物介绍-维格列汀(vildagliptin)sales@chemlink.org (admin)http://www.chemlink.org/blog/post/91.htmlThu, 14 Jan 2010 15:54:39 +0800http://www.chemlink.org/blog/post/91.htmlNewshttp://www.chemlink.org/blog/post/91.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=91http://www.chemlink.org/blog/cmd.asp?act=tb&id=91&key=7f8a3380Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinomasales@chemlink.org (admin)http://www.chemlink.org/blog/post/90.htmlFri, 18 Dec 2009 15:30:13 +0800http://www.chemlink.org/blog/post/90.htmlNewshttp://www.chemlink.org/blog/post/90.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=90http://www.chemlink.org/blog/cmd.asp?act=tb&id=90&key=ac5f1c35美国FDA的委员会同意Asteilas / Cardiome的心律失常药 Vernakalansales@chemlink.org (admin)http://www.chemlink.org/blog/post/89.htmlMon, 13 Apr 2009 14:33:42 +0800http://www.chemlink.org/blog/post/89.htmlNewshttp://www.chemlink.org/blog/post/89.html#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=89http://www.chemlink.org/blog/cmd.asp?act=tb&id=89&key=0344c7a2